Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Tempus AI
Related studies linked through entity extraction aliases.
A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE1
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
- Status
- RECRUITING
- Phase
- N/A
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
- Status
- RECRUITING
- Phase
- N/A
Liquid BiOpsy, Lung and Colon Cancer in AndaluciA
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Status
- RECRUITING
- Phase
- NA
NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial
- Status
- RECRUITING
- Phase
- NA
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
- Status
- RECRUITING
- Phase
- N/A
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Status
- RECRUITING
- Phase
- N/A
Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.
- Status
- TERMINATED
- Phase
- N/A
Addressing Under-treatment and Health Equity in AS and MR Using an Integrated EHR Platform
- Status
- COMPLETED
- Phase
- NA
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Umbrella Study for Analysis of Data Related to Patients With Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
- Status
- RECRUITING
- Phase
- N/A
GEMINI-NSCLC: NSCLC Biomarker Study
- Status
- RECRUITING
- Phase
- N/A
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
- Status
- RECRUITING
- Phase
- N/A
Tempus Priority Study: A Pan-tumor Observational Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
- Status
- TERMINATED
- Phase
- PHASE2